Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

Nonurinary sodium excretion in afebrile cirrhotic patients without diarrhea is approximately 10 mmol/day. [13] Patients with ascites on no diuretics commonly have renal sodium excretion of < 20 ...

A thrombopoietin agonist raises platelet counts in HCV-positive patients who are undergoing antiviral therapy. Cirrhotic patients who are infected with hepatitis C virus (HCV) often experience ...

MASH's economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of ...

A cross-sectional study of cardiovascular devices subject to Class I recalls from 2013 through 2022, found that most recalled devices did not undergo clinical testing before authorization and were not ...

But in the cirrhotic livers they examined, HNF4 alpha was almost nonexistent. The team needed a way to get the transcription factor into liver cells, so they turned to mRNA technology. Used in ...

In California, the animal you run over cannot be carted off to your freezer. It must stay by the side of the road. California ...

The gut microbiome has been well-established in its role of regulating the onset of many gastrointestinal disorders. Recent ...

Ascites usually occur when the liver stops working properly, leading to a buildup of fluid in the abdominal area. It is the most common complication of cirrhosis (scarring of the liver), according to ...

Ed Arce, an analyst from H.C. Wainwright, maintained the Buy rating on Akero Therapeutics (AKRO – Research Report). The associated price ...

Obeticholic acid was given accelerated approval by the FDA in May 2016 as a second-line treatment for PBC patients not ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...